Reference health
Fixed-Dose Combination Amlodipine/Celecoxib (Consensi) for Hypertension and Osteoarthritis
7/7 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
4 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 7 checked references that resolve
resolves10.1093/ajh/hpy118
Use of Prescription Medications That Potentially Interfere With Blood Pressure Control in New-Onset Hypertension and Treatment-Resistant Hypertension
resolves10.1016/S0002-9149(02)02661-9
Effects of celecoxib and rofecoxib on blood pressure and edema in patients ≥65 years of age with systemic hypertension and osteoarthritis
resolves10.1001/archinte.1995.00430100075009
The Effects of Nonsteroidal Anti-inflammatory Drugs on Blood Pressures of Patients With Hypertension Controlled by Verapamil
resolves10.1016/S0895-7061(00)01204-8
Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril
resolves10.1093/eurheartj/ehx508
Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial
resolves10.1007/s11606-016-3972-z
Effect of Combination Therapy on Adherence Among US Patients Initiating Therapy for Hypertension: a Cohort Study
resolves10.1001/jama.2018.11439
Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents
The 4 references without a DOI — listed, not checked
no DOI — not checkedConsequences of increased systolic blood pressure in patients with osteoarthritis and rheumatoid arthritis
no DOI — not checkedKitov Pharma Ltd. Study to evaluate the effect of celecoxib on the efficacy and safety of amlodipine in subjects with hypertension requiring antihypertensive therapy. Available at: https://clinicaltrials.gov/ct2/show/results/NCT02172040. NLM identifier: NCT02172040. 2017. Accessed August 23, 2018.
no DOI — not checkedKitov Pharmaceuticals. Corporate presentation. Available at: http://kitovpharma.investorroom.com/download/KitovPresentation-March2018.pdf. Published March, 2018. Accessed August 23, 2018.
no DOI — not checkedBurrell I. Kitov is trailblazer in combined treatment for osteoarthritis and hypertension. Available at: https://www.bloomberg.com/news/sponsors/kitov-pharmaceuticals/kitov-is-trailblazer-in-combined-treatment-for-osteoarthritis-and-hypertension/?adv=17613&prx_t=4LcDAx5ghAVUANA. Published June 18, 2018. Accessed August 23, 2018.
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1016/j.amjmed.2018.08.027"><img src="https://citestamp.com/citestamped/10.1016/j.amjmed.2018.08.027/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1016/j.amjmed.2018.08.027)